Search results
UL Solutions Acquires Germany-Based Battery Testing and Simulation Company BatterieIngenieure
The Auto Channel· 4 days agoNORTHBROOK, Ill.--UL Solutions Inc. , a global leader in applied safety science, today announced our acquisition of BatterieIngenieure GmbH, a battery testing company based in Aachen ...
UL Solutions bolsters EV battery testing with German acquisition By Investing.com
Investing.com· 4 days agoThis strategic move, completed today, enhances UL Solutions' capabilities in the burgeoning electric...
Cylib Closes €55M Series A For Industrial Scaling - CleanTechnica
CleanTechnica· 6 days agoCylib closes at 55M series A for Industrial scalling
German Cup Champions
San Francisco Chronicle· 18 hours ago2024 — Bayer Leverkusen 1, Kaiserslautern 0
The 145-Year-Old Giant Bringing Greener Hydrogen To The World
Forbes· 5 days agoLinde PLC puts the heavy in heavy industry. It furnishes industrial gases to the world’s...
Further strikes likely at Nestlé, Zentis, Carl Kühne plants in Germany, says union
Just Food via Yahoo Finance· 3 days agoStrikes began at two Zentis sites in Aachen on 15 May, when 150 employees staged a two-hour strike...
‘You need to have a perfect day’ – Unbound 200 defending champion Schiff prepared but pragmatic
Cyclingnews· 1 day agoLast year when Carolin Schiff crossed the line to claim victory at Unbound Gravel 200, the Canyon...
Veteran recalls being captured as prisoner of war weeks after D-Day
Press Association News via AOL· 3 days ago“We stopped out in the country each morning to empty the bin. “It was all very degrading. You had to...
Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b...
Benzinga· 1 day agoVera Therapeutics, Inc. VERA, a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases ...
HI-Bio Presents Positive Interim Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy...
WKRN Nashville· 2 days agoPatients receiving nine-dose regimen over five months experienced deep and durable reduction in proteinuria, reaching up to ~50% mean reduction in UPCR at end of study at month 24 and over 18 ...